DENTSPLY SIRONA Inc. $XRAY Shares Purchased by Nordea Investment Management AB

Nordea Investment Management AB boosted its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 71.0% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 428,015 shares of the medical instruments supplier’s stock after buying an additional 177,750 shares during the quarter. Nordea Investment Management AB’s holdings in DENTSPLY SIRONA were worth $6,853,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in XRAY. Wealth Enhancement Advisory Services LLC lifted its holdings in DENTSPLY SIRONA by 39.0% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 53,903 shares of the medical instruments supplier’s stock worth $805,000 after buying an additional 15,117 shares in the last quarter. Janney Montgomery Scott LLC lifted its holdings in DENTSPLY SIRONA by 210.5% in the 1st quarter. Janney Montgomery Scott LLC now owns 64,191 shares of the medical instruments supplier’s stock worth $959,000 after buying an additional 43,516 shares in the last quarter. Blue Trust Inc. lifted its holdings in DENTSPLY SIRONA by 57.7% in the 1st quarter. Blue Trust Inc. now owns 12,554 shares of the medical instruments supplier’s stock worth $188,000 after buying an additional 4,595 shares in the last quarter. Lecap Asset Management Ltd. acquired a new position in DENTSPLY SIRONA in the 1st quarter worth $761,000. Finally, Mirae Asset Global Investments Co. Ltd. acquired a new position in DENTSPLY SIRONA in the 1st quarter worth $25,000. Institutional investors and hedge funds own 95.70% of the company’s stock.

DENTSPLY SIRONA Price Performance

Shares of NASDAQ:XRAY opened at $12.93 on Tuesday. The company has a quick ratio of 1.11, a current ratio of 1.69 and a debt-to-equity ratio of 1.13. DENTSPLY SIRONA Inc. has a fifty-two week low of $11.69 and a fifty-two week high of $24.86. The firm has a 50-day simple moving average of $13.39 and a 200 day simple moving average of $14.52. The company has a market cap of $2.58 billion, a PE ratio of -2.73, a P/E/G ratio of 0.78 and a beta of 0.96.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings data on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share for the quarter, beating analysts’ consensus estimates of $0.50 by $0.02. DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. The business had revenue of $936.00 million during the quarter, compared to the consensus estimate of $929.67 million. During the same quarter in the prior year, the firm earned $0.49 EPS. The company’s revenue for the quarter was down 4.9% compared to the same quarter last year. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. On average, sell-side analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.

DENTSPLY SIRONA Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, October 10th. Investors of record on Friday, September 26th were given a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.9%. The ex-dividend date of this dividend was Friday, September 26th. DENTSPLY SIRONA’s dividend payout ratio is currently -13.50%.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on the stock. Stifel Nicolaus cut their price objective on shares of DENTSPLY SIRONA from $19.00 to $17.00 and set a “hold” rating on the stock in a report on Friday, August 8th. Weiss Ratings restated a “sell (d-)” rating on shares of DENTSPLY SIRONA in a research note on Wednesday, October 8th. Needham & Company LLC restated a “hold” rating on shares of DENTSPLY SIRONA in a research note on Friday, September 26th. Wall Street Zen lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Saturday. Finally, Wells Fargo & Company cut their target price on shares of DENTSPLY SIRONA from $16.00 to $15.00 and set an “equal weight” rating on the stock in a research note on Friday, August 8th. Two equities research analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $18.00.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.